Actavis Generics Acquisition Drives Teva Pharmaceutical Industries Ltd. First-Quarter Sales Higher – Motley Fool


Motley Fool
Actavis Generics Acquisition Drives Teva Pharmaceutical Industries Ltd. First-Quarter Sales Higher
Motley Fool
A boost from the acquisition of Actavis Generics from Allergan (NYSE:AGN) made the difference for Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) when the company reported its results for the fourth quarter of 2016. The addition of Actavis Generics
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Can Bounce NowInvestorplace.com
Why Teva Pharmaceutical Industries is a Top 10 SAFE International Dividend Stock (TEVA)Nasdaq
Teva Pharmaceutical Industries Ltd (ADR) Backs Forecast Amid Mixed Q1StockNews.com (blog)
Yahoo Finance -The Cerbat Gem -Zacks
all 124 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd